1. Home
  2. ODTX vs AMRC Comparison

ODTX vs AMRC Comparison

Compare ODTX & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$16.85

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo Ameresco Inc.

AMRC

Ameresco Inc.

N/A

Current Price

$20.72

Market Cap

1.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
ODTX
AMRC
Founded
2021
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2025
2010

Fundamental Metrics

Financial Performance
Metric
ODTX
AMRC
Price
$16.85
$20.72
Analyst Decision
Strong Buy
Buy
Analyst Count
8
12
Target Price
$34.67
★ $39.10
AVG Volume (30 Days)
291.0K
★ 559.5K
Earning Date
11-04-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ 0.35
Revenue
N/A
★ $1,769,928,000.00
Revenue This Year
N/A
$10.85
Revenue Next Year
N/A
$8.77
P/E Ratio
★ N/A
$65.09
Revenue Growth
N/A
N/A
52 Week Low
$15.10
$18.09
52 Week High
$29.05
$37.14

Technical Indicators

Market Signals
Indicator
ODTX
AMRC
Relative Strength Index (RSI) 36.09 44.56
Support Level $15.73 $19.06
Resistance Level $19.60 $23.87
Average True Range (ATR) 1.69 2.00
MACD -0.19 -0.16
Stochastic Oscillator 6.10 25.49

Price Performance

Historical Comparison
ODTX
AMRC

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About AMRC Ameresco Inc.

Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.

Share on Social Networks: